CY2019A - The use of bmy 14802 in the treatment of anxiety in benzodiazepine-withdrawn patients - Google Patents

The use of bmy 14802 in the treatment of anxiety in benzodiazepine-withdrawn patients

Info

Publication number
CY2019A
CY2019A CY201998A CY201998A CY2019A CY 2019 A CY2019 A CY 2019A CY 201998 A CY201998 A CY 201998A CY 201998 A CY201998 A CY 201998A CY 2019 A CY2019 A CY 2019A
Authority
CY
Cyprus
Prior art keywords
treatment
bmy
benzodiazepine
anxiety
withdrawn
Prior art date
Application number
CY201998A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CY2019A publication Critical patent/CY2019A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CY201998A 1991-10-24 1998-02-20 The use of bmy 14802 in the treatment of anxiety in benzodiazepine-withdrawn patients CY2019A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78201091A 1991-10-24 1991-10-24

Publications (1)

Publication Number Publication Date
CY2019A true CY2019A (en) 1998-02-20

Family

ID=25124656

Family Applications (1)

Application Number Title Priority Date Filing Date
CY201998A CY2019A (en) 1991-10-24 1998-02-20 The use of bmy 14802 in the treatment of anxiety in benzodiazepine-withdrawn patients

Country Status (18)

Country Link
US (1) US5278164A (xx)
EP (1) EP0538897B1 (xx)
JP (1) JPH05238934A (xx)
KR (1) KR100196334B1 (xx)
AT (1) ATE150645T1 (xx)
AU (1) AU649169B2 (xx)
CA (1) CA2081062A1 (xx)
CY (1) CY2019A (xx)
DE (1) DE69218544T2 (xx)
DK (1) DK0538897T3 (xx)
ES (1) ES2101000T3 (xx)
GR (1) GR3022945T3 (xx)
HK (1) HK113897A (xx)
IL (1) IL103499A0 (xx)
OA (1) OA09766A (xx)
PH (1) PH30028A (xx)
TW (1) TW217382B (xx)
ZA (1) ZA928105B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011091418A1 (en) * 2010-01-25 2011-07-28 Northeastern University Screening method for adverse side effects of a therapeutic pharmaceutical drug

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605655A (en) * 1984-03-06 1986-08-12 Bristol-Myers Company Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives
US5055470A (en) * 1989-06-01 1991-10-08 Bristol-Myers Squibb Co. Method of treatment of ischemia in brain

Also Published As

Publication number Publication date
KR930007452A (ko) 1993-05-20
AU649169B2 (en) 1994-05-12
CA2081062A1 (en) 1993-04-25
US5278164A (en) 1994-01-11
GR3022945T3 (en) 1997-06-30
DE69218544D1 (de) 1997-04-30
DE69218544T2 (de) 1997-11-13
EP0538897A1 (en) 1993-04-28
HK113897A (en) 1997-08-29
PH30028A (en) 1996-11-08
EP0538897B1 (en) 1997-03-26
ES2101000T3 (es) 1997-07-01
ZA928105B (en) 1993-08-25
TW217382B (xx) 1993-12-11
KR100196334B1 (ko) 1999-06-15
DK0538897T3 (da) 1997-08-25
IL103499A0 (en) 1993-03-15
AU2716592A (en) 1993-04-29
JPH05238934A (ja) 1993-09-17
ATE150645T1 (de) 1997-04-15
OA09766A (en) 1993-11-30

Similar Documents

Publication Publication Date Title
ES2043890T3 (es) Nuevo uso medico.
LTIP919A (en) Drugs and process for preparing thereof
GR3024787T3 (en) Levobupivacaine useful for managing chronic pain
EP0378692A4 (en) Catheter for medical treatment
GR3019050T3 (en) Dental adhesive
HU9301253D0 (en) Medical preparative applicable for treatment of enlarged time of coagulation
DK399288D0 (da) Dobbeltstrenget rna-korrektion af abnormiteter i cirkulerende immunkomplekser og monocytfunktion
PH25503A (en) Method of medical treatment
DK0629400T3 (da) Idebenon-holdige præparater til behandling af Alzheimer's syge
ZA981779B (en) The use of levobupivacaine in facial surgery
EP0448004A3 (en) Catheter for medical treatment
TW217382B (xx)
SE9101341D0 (sv) New medicinal use
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
ZA945431B (en) Use of benzydamine in the treatment of pathological conditions caused by TNF
EP0312132A3 (en) Veterinary and human medical remedy having an antiviral and antitumorous activity, containing 2,6-diamino-3-phenyl-azo-pyridine
HUT60145A (en) Process for producing pharmaceutical composition comprising human interleukin-2 and suitable for treating pneumothorax
UA28288A (uk) Спосіб лікування шизофренії
ZA921101B (en) Use of tetra: Hydro-thieno-pyrido-indole derivatives for the prepartion of a medicine for the treatment of skin disorders.
UA10000A (uk) Спосіб лікування гострої недостатності тканинного дихання
ITMI910442V0 (it) Struttura di zoccolo ortopedico, o simile, in particolare per la prevenzione o la cura del valgismo dell'alluce
YU15301A (sh) PRIMENA R (+)- alfa-(2,3-DIMETOKSIFENIL)-1-[2-(4-FLUOROFENIL) ETIL] -4-PIPERIDINMETANOLA ZA LECENJE POREMEĆAJA SPAVANJA
ES1019006Y (es) Jeringa de anestesia dental desechable.
DK86093D0 (da) Praeparat til medikamentel behandling for tandlaegebrug mod lidelserne tandkoedsbetaendelse og tandnervebetaendelse
UA19647A (uk) Спосіб лікуваhhя остеомієліту щелепи